These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
495 related articles for article (PubMed ID: 30476497)
1. Modeling Human Digestive Diseases With CRISPR-Cas9-Modified Organoids. Fujii M; Clevers H; Sato T Gastroenterology; 2019 Feb; 156(3):562-576. PubMed ID: 30476497 [TBL] [Abstract][Full Text] [Related]
2. Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression. Seino T; Kawasaki S; Shimokawa M; Tamagawa H; Toshimitsu K; Fujii M; Ohta Y; Matano M; Nanki K; Kawasaki K; Takahashi S; Sugimoto S; Iwasaki E; Takagi J; Itoi T; Kitago M; Kitagawa Y; Kanai T; Sato T Cell Stem Cell; 2018 Mar; 22(3):454-467.e6. PubMed ID: 29337182 [TBL] [Abstract][Full Text] [Related]
3. A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids. Okamoto T; Natsume Y; Yamanaka H; Fukuda M; Yao R STAR Protoc; 2021 Dec; 2(4):100780. PubMed ID: 34585151 [TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes. Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537 [TBL] [Abstract][Full Text] [Related]
5. Gut organoids: mini-tissues in culture to study intestinal physiology and disease. Almeqdadi M; Mana MD; Roper J; Yilmaz ÖH Am J Physiol Cell Physiol; 2019 Sep; 317(3):C405-C419. PubMed ID: 31216420 [TBL] [Abstract][Full Text] [Related]
6. Sequential cancer mutations in cultured human intestinal stem cells. Drost J; van Jaarsveld RH; Ponsioen B; Zimberlin C; van Boxtel R; Buijs A; Sachs N; Overmeer RM; Offerhaus GJ; Begthel H; Korving J; van de Wetering M; Schwank G; Logtenberg M; Cuppen E; Snippert HJ; Medema JP; Kops GJ; Clevers H Nature; 2015 May; 521(7550):43-7. PubMed ID: 25924068 [TBL] [Abstract][Full Text] [Related]
7. HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists. Fusco N; Bosari S World J Gastroenterol; 2016 Sep; 22(35):7926-37. PubMed ID: 27672288 [TBL] [Abstract][Full Text] [Related]
8. Modeling of Autism Using Organoid Technology. Choi H; Song J; Park G; Kim J Mol Neurobiol; 2017 Dec; 54(10):7789-7795. PubMed ID: 27844287 [TBL] [Abstract][Full Text] [Related]
9. Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids. Ramakrishna G; Babu PE; Singh R; Trehanpati N Hepatol Int; 2021 Dec; 15(6):1309-1317. PubMed ID: 34596864 [TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish. González F Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095 [TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-Mediated Genome Editing of Mouse Small Intestinal Organoids. Schwank G; Clevers H Methods Mol Biol; 2016; 1422():3-11. PubMed ID: 27246017 [TBL] [Abstract][Full Text] [Related]
12. Toward a CRISPR Picture: Use of CRISPR/Cas9 to Model Diseases in Human Stem Cells In Vitro. Freiermuth JL; Powell-Castilla IJ; Gallicano GI J Cell Biochem; 2018 Jan; 119(1):62-68. PubMed ID: 28544217 [TBL] [Abstract][Full Text] [Related]
13. Applications of kidney organoids derived from human pluripotent stem cells. Kim YK; Nam SA; Yang CW Korean J Intern Med; 2018 Jul; 33(4):649-659. PubMed ID: 29961307 [TBL] [Abstract][Full Text] [Related]
14. Organoid Models of Human Gastrointestinal Development and Disease. Dedhia PH; Bertaux-Skeirik N; Zavros Y; Spence JR Gastroenterology; 2016 May; 150(5):1098-1112. PubMed ID: 26774180 [TBL] [Abstract][Full Text] [Related]
15. Organoids derived from digestive tract, liver, and pancreas. Xu AT; Tong JL; Ran ZH J Dig Dis; 2016 Jan; 17(1):3-10. PubMed ID: 26666830 [TBL] [Abstract][Full Text] [Related]
16. Obesity-associated digestive cancers: A review of mechanisms and interventions. Zheng J; Zhao M; Li J; Lou G; Yuan Y; Bu S; Xi Y Tumour Biol; 2017 Mar; 39(3):1010428317695020. PubMed ID: 28351315 [TBL] [Abstract][Full Text] [Related]
17. Current concepts in gastrointestinal pathology. Garcia-Buitrago M; Montgomery EA Pathology; 2022 Mar; 54(2):145-146. PubMed ID: 35031085 [No Abstract] [Full Text] [Related]
18. CRISPR/Cas 9 genome editing and its applications in organoids. Driehuis E; Clevers H Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G257-G265. PubMed ID: 28126704 [TBL] [Abstract][Full Text] [Related]
19. Organoids for the Study of Liver Cancer. Wang H; Calvisi DF; Chen X Semin Liver Dis; 2021 Jan; 41(1):19-27. PubMed ID: 33764482 [TBL] [Abstract][Full Text] [Related]
20. Generation of Knockout Gene-Edited Human Intestinal Organoids. Rajendra C; Wald T; Barber K; Spence JR; Fattahi F; Klein OD Methods Mol Biol; 2020; 2171():215-230. PubMed ID: 32705644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]